Comparison of the efficacy, safety and tolerability of telmisartan with losartan in Indian patients with mild to moderate hypertension: A pilot study

Journal of the Indian Medical Association

Volumn 101, Issue 5, 2003, Pages 327-328

  Samra, S S ^a   Dongre, Neelesh ^b   Ballary, Chetna ^b   Desai, Anish ^b  

^a St George's Hospital   (India)

^b Glenmark Pharmaceuticals Limited   (India)

Author keywords

Efficacy; Hypertension; Losartan; Safety; Telmisartan

Indexed keywords

HYDROCHLOROTHIAZIDE; LOSARTAN; TELMISARTAN;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EVALUATION; FEMALE; HEADACHE; HUMAN; HYPERTENSION; INDIA; LABORATORY DIAGNOSIS; MALE; PHYSICAL EXAMINATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE; VERTIGO;

EID: 0141963430     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Sowers JR, Epstein M - Diabetes mellitus and hypertension, emerging therapeutic perspectives. Cardiovasc Drug Rev 1995; 13: 149-210.
2. Lindgren BR, Andersson RG - Angiotensin-converting enzyme inhibitors and their influence on inflammation, bronchial reactivity and cough: a research review. Med Toxicol Adverse Drug Exp 1989; 4: 369-80.
3. Dzau VJ - Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart. Basic Res Cardiol 1993; 88: 1-14.
4. Wienen W, Hauel N, Van Meel JC, Narr B, Ries U, Entzeroth M - Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277. Br J Pharmacol 1993; 110: 245-52.
5. Neutel JM, Smith DH - Dose response and antihypertensive efficacy of the AT1 receptor antagonist telmisartan in patients with mild to moderate hypertension. Adv Ther 1998; 15: 206-17.
6. Smith DH, Matzek KM, Kempthorne-Rawson J - Dose response and safety of telmisartan in patients with mild to moderate hypertension. J Clin Pharmacol 2000; 40: 1380-90.
7. Gradman AH, Arcuri KE, Goldberg AI, Ikeda LS, Nelson EB, Snavely DB, et al - A randomized, placebo controlled, double blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension. Hypertension 1995; 25: 1345-50.
8. Mallion JM, Siche JP - ABPM comparison, of the antihypertensive profiles of the selective angiotensin II receptor antagonists, telmisartan and losartan in patients with mild to moderate hypertension. J Hum Hypertens 1999; 13: 657-64.
9. Kolloch RE, Neutel JM - Comparison of telmisartan monotherapy with losartan + hydrochlorthiazide in mild to moderate hypertension. J Hypertens 2000; 18: 597.
10. Lacourciere Y, Lenis J, Orchard R, et al - A comparison of the efficacies and duration of action of the angiotensin II receptor blockers telmisartan and amlodipine. Blood Press Monit 1998; 3: 295-302.
11. Littlejohn T, Mroczek W, Marbury T, et al - A prospective, randomized, open-label trial comparing telmisartan 80mg with valsartan 80mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring. Can J Cardiol 2000; 16: 1123-32.
12. American Diabetes Association - Treatment of hypertension in adults with diabetes. Diabetes Care 2003; 26: 80-2.
13. Stengier J - Pharmacokinetics of single dose telmisartan 120mg given during and between hemodialysis in subjects with renal insufficiency. J Clin Pharmacol 2000; 40: 1365-72.